Tag: Human Papillomavirus (HPV)
Many Lack Knowledge of Link Between HPV and Oropharyngeal Cancer
No change seen in knowledge of the association from 2018 to 2020 among adults, focusing on those aged 27 to 45 years
Vaccination of 27- to 45-Year-Olds Against HPV Is Less Cost-Effective
Vaccination of 'mid-adults,' including those at higher risk, results in higher number needed to vaccinate than that seen for younger people
Women Want a Choice Between Vaginal HPV Self-Sampling and Clinician Screen
However, some feel it would be difficult to choose
One-Dose HPV Vaccination Averts Similar Number of Cancers as Two Doses
Under most pessimistic scenario, one dose would avert fewer cervical cancer cases with difference of 3 percent over 100 years
Comprehensive HPV Screening Important in Male Urology, Fertility Clinics
Men with high-risk HPV had significantly higher levels of sperm necrosis; increased proportions of ROS-positive spermatozoa
2007 to 2020 Saw Continuous Decrease in Cervical Cancer in Younger Women
During same period, significant increase was seen in incidence of CIN3 among those aged 25 to 29 years
Vaginal Cancer Incidence Increasing Globally
Risk factors include unsafe sex and HIV infection
Guidelines Address RT for Management of HPV-Linked Oropharyngeal Cancer
Tailored recommendations presented to maximize survival and minimize side effects
At-School Vaccination Boosts HPV Vaccination Coverage
No significant effect seen for increasing adolescent, parent, and provider education
Quality Improvement Initiative Boosts Early HPV Vaccine Rates
Findings show significant increases across racial/ethnic, sociodemographic, insurance, and geographic groups
